Mol. Cells 2022; 45(4): 231-242
Published online April 30, 2022
© The Korean Society for Molecular and Cellular Biology
Although the NMJ has been shown to have a potential association with disease mechanisms of peripheral neuropathy, including CMT and dHMN5, effective NMJ- or GARS-targeted therapy has not been explored for this disorder.
Therapeutic Potential of CKD-504, a Novel Selective Histone Deacetylase 6 Inhibitor, in a Zebrafish Model of Neuromuscular Junction Disorders
COMMENT: Manually corrected date. Publisher listed April 30, 2022, which is in the future. Only the PDF version of the article revealed the correct date: March 30, 2022.